![]() |
|
|||||||||
|
Great Lakes Region
FDA Inspection: Lansing, MI (04/22/10) SNIPPET | DOWNLOAD
Recalls and Significant Blood Safety Violations
10/30/09: Recalled 1 Red Blood Cells Leukocytes Reduced Product due to donor eligibility (failure to defer donor for travel to a malarial risk area). 10/30/09: Recalled 1 Platelets Leukocytes Reduced Product due to donor eligibility (failure to defer donor for travel to a malarial risk area). 10/30/09: Recalled 1 Red Blood Cells Leukocytes Reduced Product due to component preparation (product manufactured from an overweight unit of Whole Blood). 10/30/09: Recalled 4 Red Blood Cells (Apheresis) Leukocytes Reduced Products due to component preparation (failure to per- form required product quality control testing). 10/30/09: Recalled 1 Red Blood Cells Leukocytes Reduced Product due to donor eligibility (incorrect gender assigned; incorrect Blood Donation Record gender-specific questions answered). 10/30/09: Recalled 1 Red Blood Cells Leukocytes Reduced Product due to donor eligibility (failure to defer donor for travel to a malarial risk area). 10/30/09: Recalled 1 Platelets Leukocytes Reduced Product due to donor eligibility (failure to defer donor for travel to a malarial risk area). 10/30/09: Recalled 1 Red Blood Cells Reduced Product due to component preparation (product manufactured from an overweight unit of Whole Blood). 2/6/08: Recalled 1 Red Blood Cells Leukocytes Reduced Product due to donor eligibility (failure to defer donor for travel in a malarial risk area). 2/6/08: Recalled 1 Platelets Leukocytes Reduced Product due to donor eligibility (failure to defer donor for travel in a malarial risk area). 2/6/08: Recalled 1 Red Blood Cells Leukocytes Reduced Product due to donor eligibility (failure to defer donor for travel in a malarial risk area). 2/6/08: Recalled 1 Red Blood Cells Leukocytes Reduced Product due to donor eligibility (failure to defer donor for travel in a malarial risk area). 2/6/08: Recalled 1 Platelets Leukocytes Product due to donor eligibility (failure to defer donor for travel in a malarial risk area). The following excerpt is from page 2 of this 2-page FDA Inspection Report:Case id #(b)(4) was for a donor reaction involving a 4 1/2" bruise reported by donor call back on 11/20/09. This record has not had Medical Director Review or Final Quality Review as of 4/22/10. Download the pdf file to read the complete inspection report. |
||||||||||